CLINICAL_TRIALS
trial_result
· 2020-01-13
Clinical Trial Update: Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers [Phase 2]
Summary
Phase 2 trial results of enzalutamide in patients with androgen receptor–positive salivary gland cancer have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Salivary Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2020-01-13